NEW: 'Kairos' cLDEP Particle Sorter   More info...

News

  • Apr 2015
    ApogeeMix Special Offer

    For a limited period Apogee is offering its ApogeeMix bead mixture (Cat#1493, ApogeeMix, latex fluorescent 110 & 500nm plus silica 180, 240, 300, 590, 880 & 1300nm, 25ml) at the reduced price of GBP135 or US$200.

    The item may be ordered by emailing your purchase order to info@apogeeflow.com Quote code “ApoMix” to make sure you receive the special offer price.

  • Apr 2015
    Visit Apogee at CYTO 2015
    Visit Apogee at CYTO 2015 booth 520 where the new Micro+ model will be on display. The Micro+ offers uncompromised performance for microvesicle, virus and nanoparticle research.

    CYTO 2015
    XXX Congress of the International Society for Advancement of Cytometry
    June 26 - 30, 2015, Glasgow, Scotland
  • Mar 2015
    New Apogee Software Release

    PC Control v3-44 and Apogee Histogram Software v242

    Includes:

    • Minimum sample volume now reduced to 50μl (previously 120μl)
    • Bug fix when applying protocols/templates to the current data
    • More efficient datafile format (reduced file size when fewer than 12 optical detectors are enabled)
    • Improved compatibility with FlowJo and other third party FCS3 compatible software (e.g. fluorescence compensation settings now exported)
  • Feb 2015
    New Patent Notice of Allowance
    Apogee's refractive index compensated light scatter size calibration method is allowed for issuance as a patent. This addition to Apogee's patents further strengthens its position as a leader in small particle flow cytometry. This novel technology is well suited to bacteria and microvesicle flow cytometry.
  • Apr 2014
    GEIVEX - Tarragona, October 2014
    Apogee will sponsor the 2nd symposium in extracellular vesicles organized by GEIVEX (Grupo Espanol de Innovacion e Investigacion en Vesiculas Extracelulares). This meeting on 9th & 10th October 2014 in Tarragona will focus on recent advances in Extracellular Vesicle research.
< | Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next | >
Get In Touch
Visit our Facebook page Follow us on Twitter Connect with us on LinkedIn